News

Clinical Trials Arena1h
Arrowhead doses first patient in Phase III trial of zodasiran for HoFH treatment
Arrowhead has dosed the first participant in the Phase III YOSEMITE trial of zodasiran, under development for treating HoFH.
Clinical Trials Arena19h
Taiho’s DMD therapy misses the mark in Phase III trial
Taiho Pharmaceutical’s investigational Duchenne muscular dystrophy (DMD) therapy, pizuglanstat, has shown no benefit in a Phase III trial.
Clinical Trials Arena19h
UroGen concludes enrolment in Phase III trial of UGN-103 for bladder cancer
UroGen Pharma has completed the enrolment of subjects in its Phase III UTOPIA trial, which is evaluating UGN-103 for intravesical solution.